Dual-Channel TENS & EMS Muscle Stimulator (Models TS1111, TS4111)
Changsha Anxiang Medical Technology Co., Ltd. · Decision date Oct 30, 2026
What did the FDA decide?
FDA recorded a substantial equivalence (SESE) decision on 2026-10-30 for K262470, a Dual-Channel TENS & EMS Muscle Stimulator submitted by Changsha Anxiang Medical Technology Co., Ltd. The device is listed under product code NGX in the Physical Medicine specialty, with models TS1111 and TS4111 named in the title. The record shows the application was received 07/17/2026.
SESE denotes 510(k) clearance rather than PMA approval, and the record does not identify a predicate device or summarize the basis for the equivalence finding. The source also does not describe the device's components, waveforms, output specifications, or labeled indications, so the scope of the cleared labeling remains unknown from this data. No clinical or performance conclusions are drawn here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Physical Medicine
- Decision date
- Oct 30, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262470
- Regulatory pathway
- 510(k) premarket notification
- Product code
- NGX
- Decision code
- SESE
- Decision date
- Oct 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, Muscle, Powered, For Muscle Conditioning.
- Product code
- NGX
- FDA device class
- 2
FDA decision timeline
K262470 received
Application receipt date recorded by FDA.
K262470 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NGX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Fit-Pro KFT (Ltd.) - DBA E-Fit | 510(k) clearance | Sep 27, 2026 | FDA | |
| Beijing Winkonlaser Technology Limited | 510(k) clearance | Aug 13, 2026 | FDA | |
DiacoreK253926 | ShenB Co., Ltd. | 510(k) clearance | Apr 10, 2026 | FDA |
Zionic Pro Max (EMS)K253636 | Termosalud S.L. | 510(k) clearance | Mar 12, 2026 | FDA |
CoolToneK253408 | ZIMMER MEDIZINSYSTEME GMBH | 510(k) clearance | Jan 16, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Changsha Anxiang Medical Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Changsha
Sources and methodology
- Original FDA record: K262470
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


